| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | DE102005034484A1 Verfahren zur Herstellung von Glimepirid enthaltenden pharmazeutischen Zusammensetzungen Process for the preparation of pharmaceutical compositions containing glimepiride |
| 02/01/2007 | DE102005034406A1 Neue Salze von Rosiglitazon New salts of rosiglitazone |
| 02/01/2007 | CA2617042A1 Spiro-cyclic compound |
| 02/01/2007 | CA2615718A1 Aniline sulfonamide derivatives and their uses |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1748048A1 Imidazopyridine compound |
| 01/31/2007 | EP1747780A1 Drug for prevention or treatment of diabetes |
| 01/31/2007 | EP1747778A1 Antifatigue composition |
| 01/31/2007 | EP1747199A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/31/2007 | EP1746992A2 Use of n-substituted imino sugars for appetite suppression |
| 01/31/2007 | EP1746987A2 Dna pkinase inhibitors for treating cancer and diabetes |
| 01/31/2007 | EP1746984A2 Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity |
| 01/31/2007 | EP1746982A2 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis and cardiovascular diseases |
| 01/31/2007 | EP1303541A4 Gel compositions containing metronidazole |
| 01/31/2007 | EP1194138B1 Nutritional supplements |
| 01/31/2007 | CN1906296A Methods for the production of apolipoproteins in transgenic plants |
| 01/31/2007 | CN1906176A Therapeutic agents II |
| 01/31/2007 | CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/31/2007 | CN1906169A Therapeutic agents I |
| 01/31/2007 | CN1905903A Ghrelin-carrier conjugates |
| 01/31/2007 | CN1905878A Compounds for the sustained reduction of body weight |
| 01/31/2007 | CN1905875A The use of quaternary pyridinium salts as vasoprotective agents |
| 01/31/2007 | CN1905863A Methods and compositions for the treatment of metabolic disorders |
| 01/31/2007 | CN1905810A Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
| 01/31/2007 | CN1904900A Human autogenous siRNA sequence, its application and screening method |
| 01/31/2007 | CN1903364A Medicine composition contg. inhibitor of angiotonase and phenoxy acid compounds |
| 01/31/2007 | CN1903350A Turmeric prepn. for treating hyperlipidemia |
| 01/31/2007 | CN1903339A Medicine for treating diabetes |
| 01/31/2007 | CN1903331A Traditional Chinese medicine powder for lowering hyperglycosuria and restoration |
| 01/31/2007 | CN1903325A Blood-sugar lowering A prepn. for treating diabetes, its prepn. method and quality-control method |
| 01/31/2007 | CN1903323A Capsule for treating diabetes |
| 01/31/2007 | CN1903320A Decoction liquor for moistening dryness and tonifying-qi |
| 01/31/2007 | CN1903319A Oral liquor for lowering blood sugar |
| 01/31/2007 | CN1903318A Traditional Chinese medicine decoction liquor for helping produce saliva and slake thirst |
| 01/31/2007 | CN1903317A Traditional Chinese medicine decoction liquor for relieving thirst |
| 01/31/2007 | CN1903316A Traditional Chinese medicine composition for eliminating-toxins and removing-fat, prepn. method therefor |
| 01/31/2007 | CN1903302A Traditional Chinese medicine liquor for improving-Yang and treating diabete thristy disease |
| 01/31/2007 | CN1903278A Pure natural nutrient substance and its prepn. method |
| 01/31/2007 | CN1903242A Total saponin of American ginseng and injection liquid thereof |
| 01/31/2007 | CN1903236A Medicine composition having activity of anti-diatebes |
| 01/31/2007 | CN1903235A Novel process for preparing scabish oil |
| 01/31/2007 | CN1903232A Moringaceae powder nutrition food and method for preparing the same |
| 01/31/2007 | CN1903226A Extracting method for fat-lowering active component of melissa powder |
| 01/31/2007 | CN1903220A Health-care food with function of improving skeletal density and its prepn. method |
| 01/31/2007 | CN1903219A Abalone shell calcium complement agent and its prepn. method |
| 01/31/2007 | CN1903215A Method for preparing calcium ion powder |
| 01/31/2007 | CN1903210A Use of pachycladous algal onychin |
| 01/31/2007 | CN1903209A Weight-reducing compound prepn. and its prepn. method |
| 01/31/2007 | CN1903207A Fat-soluble vitamin freeze-dried prepn. and its prepn. method |
| 01/31/2007 | CN1903195A Gliclazide delayed-release dripping pills for treating diabetes |
| 01/31/2007 | CN1903194A Slow-release, controlled-release prepn. of simvastatin, and method for preparing same |
| 01/31/2007 | CN1903193A Use of Naka-furan-8-lactone |
| 01/31/2007 | CN1297653C Composition comprising a lactobacillus pentosus strain and uses thereof |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297540C New derivatives of pyridilethanol (phenylethyl) amines as cholesterol biosynthesis inhibitors, procedures of their preparation and pharmaceutical preparations which they contain |
| 01/31/2007 | CN1297527C Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/31/2007 | CN1297307C Infusion of gen-seng, lilyturf root and amino acid and its preparing method |
| 01/31/2007 | CN1297301C Application of cocoa extract in preparing medication of preventing and improving fatness and clinical symptom, and foodstuff |
| 01/31/2007 | CN1297300C Extract of cocoa tea in application for preparing medication and foodstuff of preventing and improving diabetes and clinical symptom |
| 01/31/2007 | CN1297287C Compound red sage root and amino acid infusion and its preparing method |
| 01/31/2007 | CN1297283C Superfine fresh bone with marrow high calcium powder capsule |
| 01/31/2007 | CN1297277C Laminaran granule and its preparation technology |
| 01/31/2007 | CN1297273C Pyrroloquinoline containing composition for enriching zinc and reducing plumbum |
| 01/31/2007 | CN1297266C Stabilized ascorbic acid derivatives |
| 01/31/2007 | CN1297265C Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/31/2007 | CN1297263C Calcium gluconate oral disintegrating tablet and its preparation process |
| 01/31/2007 | CN1297255C Dripping pills for treating high blood fat and its preparing method |
| 01/31/2007 | CN1297253C Medicinal transferring system for intracephalic transference of medicine |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169810 Phenylalkyleneoxybenzene derivatives; insulin resistance; diabetes, obesity, dyslipidemia treatment; hypotensive agents |
| 01/30/2007 | US7169806 Antidiabetic agents |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169796 Polyarylcarboxamides useful as lipid lowering agents |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169786 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169773 Compounds |
| 01/30/2007 | US7169761 Azulene derivatives and salts thereof |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169379 Cosmetics |
| 01/30/2007 | CA2394861C N6 heterocyclic 8-modified adenosine derivatives |
| 01/30/2007 | CA2266401C Use of sibutramine analogues to prevent the development of diabetes |
| 01/30/2007 | CA2166704C Arsenic medicaments for the treatment of chronic fatigue syndrome |
| 01/25/2007 | WO2007011811A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011809A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011286A1 Therapeutic agents |